Pelland, A.-A.; Dumas, M.; Lemieux-Blanchard, É.; LeBlanc, R.; Côté, J.; Boudreault, J.-S.; Duquette, D.; Kaedbey, R.; Lalancette, M.; Larose, F.;
et al. Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma. Curr. Oncol. 2025, 32, 238.
https://doi.org/10.3390/curroncol32040238
AMA Style
Pelland A-A, Dumas M, Lemieux-Blanchard É, LeBlanc R, Côté J, Boudreault J-S, Duquette D, Kaedbey R, Lalancette M, Larose F,
et al. Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma. Current Oncology. 2025; 32(4):238.
https://doi.org/10.3390/curroncol32040238
Chicago/Turabian Style
Pelland, Andrée-Anne, Mathilde Dumas, Émilie Lemieux-Blanchard, Richard LeBlanc, Julie Côté, Jean-Samuel Boudreault, Dominic Duquette, Rayan Kaedbey, Marc Lalancette, Frédéric Larose,
and et al. 2025. "Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma" Current Oncology 32, no. 4: 238.
https://doi.org/10.3390/curroncol32040238
APA Style
Pelland, A.-A., Dumas, M., Lemieux-Blanchard, É., LeBlanc, R., Côté, J., Boudreault, J.-S., Duquette, D., Kaedbey, R., Lalancette, M., Larose, F., Nikonova, A., Pavic, M., Shamy, A., Roy, J., Sebag, M., Trudel, S., & Claveau, J.-S.
(2025). Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma. Current Oncology, 32(4), 238.
https://doi.org/10.3390/curroncol32040238
